HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 274 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.48 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $7,000 | -78.8% | 170 | -77.1% | 0.00% | -100.0% |
| Q2 2022 | $33,000 | +266.7% | 741 | +223.6% | 0.00% | – |
| Q1 2022 | $9,000 | +125.0% | 229 | +112.0% | 0.00% | – |
| Q3 2021 | $4,000 | -50.0% | 108 | -35.3% | 0.00% | – |
| Q2 2021 | $8,000 | +60.0% | 167 | +47.8% | 0.00% | – |
| Q1 2021 | $5,000 | +400.0% | 113 | +653.3% | 0.00% | – |
| Q4 2020 | $1,000 | -83.3% | 15 | -93.0% | 0.00% | – |
| Q3 2020 | $6,000 | 0.0% | 214 | 0.0% | 0.00% | – |
| Q2 2020 | $6,000 | – | 214 | +919.0% | 0.00% | – |
| Q4 2019 | $0 | -100.0% | 21 | -97.9% | 0.00% | -100.0% |
| Q4 2018 | $14,000 | -78.8% | 983 | -72.8% | 0.00% | -80.0% |
| Q3 2018 | $66,000 | -99.9% | 3,608 | -28.1% | 0.01% | -28.6% |
| Q2 2018 | $84,706,000 | +445721.1% | 5,021 | +426.9% | 0.01% | +250.0% |
| Q1 2018 | $19,000 | +533.3% | 953 | +417.9% | 0.00% | – |
| Q3 2017 | $3,000 | -57.1% | 184 | -64.2% | 0.00% | -100.0% |
| Q2 2017 | $7,000 | -22.2% | 514 | -25.0% | 0.00% | 0.0% |
| Q1 2017 | $9,000 | -10.0% | 685 | -33.8% | 0.00% | 0.0% |
| Q4 2016 | $10,000 | -93.5% | 1,035 | -94.2% | 0.00% | -93.3% |
| Q2 2016 | $155,000 | – | 17,955 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |